Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Viruses ; 7(11): 5875-88, 2015 Nov 12.
Article in English | MEDLINE | ID: mdl-26569291

ABSTRACT

High consequence human pathogenic viruses must be handled at biosafety level 2, 3 or 4 and must be rendered non-infectious before they can be utilized for molecular or immunological applications at lower biosafety levels. Here we evaluate psoralen-inactivated Arena-, Bunya-, Corona-, Filo-, Flavi- and Orthomyxoviruses for their suitability as antigen in immunological processes and as template for reverse transcription PCR and sequencing. The method of virus inactivation using a psoralen molecule appears to have broad applicability to RNA viruses and to leave both the particle and RNA of the treated virus intact, while rendering the virus non-infectious.


Subject(s)
Antiviral Agents/metabolism , Ficusin/metabolism , Microbial Viability/drug effects , RNA Viruses/drug effects , RNA Viruses/physiology , Virus Inactivation , Animals , Antigens, Viral/immunology , Cell Line , Humans , RNA Viruses/genetics , RNA Viruses/immunology , RNA, Viral/genetics
2.
Microsc Microanal ; 20(1): 238-44, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24503289

ABSTRACT

Bacterial endospores are resistant to many environmental factors from temperature extremes to ultraviolet irradiation and are generally more difficult to inactivate or kill than vegetative bacterial cells. It is often considered necessary to treat spores or samples containing spores with chemical fixative solutions for prolonged periods of time (e.g., 1-21 days) to achieve fixation/inactivation to enable electron microscopy (EM) examination outside of containment laboratories. Prolonged exposure to chemical fixatives, however, can alter the ultrastructure of spores for EM analyses. This study was undertaken to determine the minimum amount of time required to inactivate/sterilize and fix spore preparations from several bacterial species using a universal fixative solution for EM that maintains the ultrastructural integrity of the spores. We show that a solution of 4% paraformaldehyde with 1% glutaraldehyde inactivated spore preparations of Bacillus anthracis, Bacillus cereus, Bacillus megaterium, Bacillus thuringiensis, and Clostridium perfringens in 30 min, and Bacillus subtilis in 240 min. These results suggest that this fixative solution can be used to inactivate and fix spores from several major groups of bacterial spore formers after 240 min, enabling the fixed preparations to be removed from biocontainment and safely analyzed by EM outside of biocontainment.


Subject(s)
Bacillus/ultrastructure , Clostridium perfringens/ultrastructure , Microbial Viability/drug effects , Spores, Bacterial/ultrastructure , Bacillus/drug effects , Clostridium perfringens/drug effects , Colony Count, Microbial , Fixatives/pharmacology , Formaldehyde/pharmacology , Glutaral/pharmacology , Microscopy, Electron, Scanning , Polymers/pharmacology , Spores, Bacterial/drug effects
3.
J Forensic Sci ; 59(2): 463-9, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24261870

ABSTRACT

The U.S. agricultural sector is vulnerable to intentionally introduced microbial threats because of its wide and open distribution and economic importance. To investigate such events, forensically valid assays for plant pathogen detection are needed. In this work, real-time PCR assays were developed for three model plant pathogens: Pseudomonas syringae pathovar tomato, Xylella fastidiosa, and Wheat streak mosaic virus. Validation included determination of the linearity and range, limit of detection, sensitivity, specificity, and exclusivity of each assay. Additionally, positive control plasmids, distinguishable from native signature by restriction enzyme digestion, were developed to support forensic application of the assays. Each assay displayed linear amplification of target nucleic acid, detected 100 fg or less of target nucleic acid, and was specific to its target pathogen. Results obtained with these model pathogens provide the framework for development and validation of similar assays for other plant pathogens of high consequence.


Subject(s)
Potyvirus/genetics , Pseudomonas syringae/genetics , Xylella/genetics , Bioterrorism , Citrus/microbiology , DNA, Bacterial/isolation & purification , DNA, Viral/isolation & purification , Limit of Detection , Solanum lycopersicum/microbiology , Real-Time Polymerase Chain Reaction , Reproducibility of Results , Triticum/virology , Vitis/microbiology
4.
Biosecur Bioterror ; 11(2): 107-17, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23675878

ABSTRACT

Molecular bioforensic research is dependent on rapid and sensitive methods such as real-time PCR (qPCR) for the identification of microorganisms. The use of synthetic positive control templates containing small modifications outside the primer and probe regions is essential to ensure all aspects of the assay are functioning properly, including the primers and probes. However, a typical qPCR or reverse transcriptase qPCR (qRT-PCR) assay is limited in differentiating products generated from positive controls and biological samples because the fluorescent probe signals generated from each type of amplicon are indistinguishable. Additional methods used to differentiate amplicons, including melt curves, secondary probes, and amplicon sequencing, require significant time to implement and validate and present technical challenges that limit their use for microbial forensic applications. To solve this problem, we have developed a novel application of electrospray ionization mass spectrometry (ESI-MS) to rapidly differentiate qPCR amplicons generated with positive biological samples from those generated with synthetic positive controls. The method has sensitivity equivalent to qPCR and supports the confident and timely determination of the presence of a biothreat agent that is crucial for policymakers and law enforcement. Additionally, it eliminates the need for time-consuming methods to confirm qPCR results, including development and validation of secondary probes or sequencing of small amplicons. In this study, we demonstrate the effectiveness of this approach with microbial forensic qPCR assays targeting multiple biodefense agents (bacterial, viral, and toxin) for the ability to rapidly discriminate between a positive control and a positive sample.


Subject(s)
Bioterrorism/prevention & control , DNA, Bacterial/analysis , Forensic Sciences/methods , RNA, Viral/analysis , Real-Time Polymerase Chain Reaction/methods , Reverse Transcriptase Polymerase Chain Reaction/methods , Spectrometry, Mass, Electrospray Ionization , Clostridium botulinum type F/genetics , Gram-Negative Bacteria/genetics , Hendra Virus/genetics , Nipah Virus/genetics , Polymorphism, Single Nucleotide , Sensitivity and Specificity
5.
Genome Announc ; 1(1)2013 Jan.
Article in English | MEDLINE | ID: mdl-23405332

ABSTRACT

The Bacillus anthracis Carbosap genome, which includes the pXO1 and pXO2 plasmids, has been shown to encode the major B. anthracis virulence factors, yet this strain's attenuation has not yet been explained. Here we report the draft genome sequence of this strain, and a comparison to fully virulent B. anthracis.

6.
Emerg Infect Dis ; 18(8): 1307-13, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22840345

ABSTRACT

In December 2009, two unusual cases of anthrax were diagnosed in heroin users in Scotland. A subsequent anthrax outbreak in heroin users emerged throughout Scotland and expanded into England and Germany, sparking concern of nefarious introduction of anthrax spores into the heroin supply. To better understand the outbreak origin, we used established genetic signatures that provided insights about strain origin. Next, we sequenced the whole genome of a representative Bacillus anthracis strain from a heroin user (Ba4599), developed Ba4599-specific single-nucleotide polymorphism assays, and genotyped all available material from other heroin users with anthrax. Of 34 case-patients with B. anthracis-positive PCR results, all shared the Ba4599 single-nucleotide polymorphism genotype. Phylogeographic analysis demonstrated that Ba4599 was closely related to strains from Turkey and not to previously identified isolates from Scotland or Afghanistan, the presumed origin of the heroin. Our results suggest accidental contamination along the drug trafficking route through a cutting agent or animal hides used to smuggle heroin into Europe.


Subject(s)
Anthrax/epidemiology , Bacillus anthracis/genetics , Disease Outbreaks , Heroin , Molecular Epidemiology , Substance Abuse, Intravenous , Anthrax/diagnosis , Anthrax/microbiology , Bacillus anthracis/isolation & purification , Bacterial Typing Techniques , DNA, Bacterial/analysis , DNA, Bacterial/genetics , Europe/epidemiology , Female , Genome, Bacterial , Genotype , Humans , Male , Phylogeny , Polymerase Chain Reaction , Polymorphism, Single Nucleotide , Sequence Analysis, DNA , Substance Abuse, Intravenous/complications , Substance Abuse, Intravenous/epidemiology
7.
Virus Genes ; 36(2): 401-13, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18278548

ABSTRACT

Foot-and-mouth disease virus (FMDV) isolates collected from various geographic locations in Afghanistan between 2003 and 2005 were genetically characterized, and their phylogeny was reconstructed utilizing nucleotide sequences of the complete VP1 coding region. Three serotypes of FMDV (types A, O, and Asia 1) were identified as causing clinical disease in Afghanistan during this period. Phylogenetic analysis revealed that the type A viruses were most closely related to isolates collected in Iran during 2002-2004. This is the first published report of serotype A in Afghanistan since 1975, therefore indicating the need for inclusion of serotype A in vaccine formulations that will be used to control disease outbreaks in this country. Serotype O virus isolates were closely related to PanAsia strains, including those that originated from Bhutan and Nepal during 2003-2004. The Asia 1 viruses, collected along the northern and eastern borders of Afghanistan, were most closely related to FMDV isolates collected in Pakistan during 2003 and 2004. Data obtained from this study provide valuable information on the FMDV serotypes circulating in Afghanistan and their genetic relationship with strains causing FMD in neighboring countries.


Subject(s)
Capsid Proteins/genetics , Foot-and-Mouth Disease Virus/genetics , Foot-and-Mouth Disease/epidemiology , Foot-and-Mouth Disease/virology , Genes, Viral , Phylogeny , Afghanistan/epidemiology , Amino Acid Sequence , Animals , Base Sequence , Capsid Proteins/chemistry , Cattle , Foot-and-Mouth Disease Virus/classification , Foot-and-Mouth Disease Virus/isolation & purification , Molecular Epidemiology , Molecular Sequence Data , RNA, Viral/analysis , RNA, Viral/genetics , Sequence Alignment , Serotyping
10.
Am J Trop Med Hyg ; 72(2): 189-97, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15741556

ABSTRACT

We conducted a randomized, double-blind, phase III yellow fever (YF) vaccine trial among 1,107 healthy children in Sullana in northern Peru. The safety and efficacy (by measurement of geometric mean neutralizing antibody titer responses) were determined for two YF vaccines, ARILVAX (n = 738) and YF-VAX(R) (n = 369). Serocon-version rates were higher (94.9%) in ARILVAX than in YF-VAX (90.6%) recipients. The two-sided 95% confidence interval (YF-VAX-ARILVAX) was (-12.8% to -2.5%), indicating that the higher seroconversion rate for Arilvax was significant. Post-vaccination (30-day) mean log(10) neutralization indices were found to be similar for both products: 1.32 for ARILVAX and 1.26 for YF-VAX (P = 0.1404, by analysis of variance). A similar number of subjects in each group reported at least one adverse event (AE); 441 (59.8%) for ARILVAX versus 211 (59.9%) for YF-VAX. Most (591; 96.7%) of these were of a mild nature and resolved without treatment. There were no treatment-related serious AEs. This is the first randomized, double-blind comparison of two YF vaccines in a pediatric population; both vaccines were shown to be highly immunogenic and well-tolerated.


Subject(s)
Yellow Fever Vaccine/therapeutic use , Yellow Fever/prevention & control , Yellow fever virus/immunology , Antibodies, Viral/blood , Child , Child, Preschool , Female , Humans , Infant , Male , Neutralization Tests , Peru/epidemiology , Treatment Outcome , Vaccination , Yellow Fever/blood , Yellow Fever/epidemiology , Yellow Fever/etiology , Yellow Fever/immunology , Yellow Fever Vaccine/adverse effects
11.
Am J Trop Med Hyg ; 72(1): 42-6, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15728866

ABSTRACT

In August 2002, two cases of hantavirus pulmonary syndrome (HPS) were confirmed in Mineros and Concepcion, within the Santa Cruz Department of Bolivia. Extensive alteration of the native ecosystem, from dense forest to pasture or sugarcane, had occurred in both regions. An ecologic assessment of reservoir species associated with the human disease identified a single hantavirus antibody-positive Oligoryzomys microtis from Mineros and three hantavirus antibody-positive Calomys callosus from Concepcion. In Mineros, the virus from the O. microtis was 90% similar to sequences published for Rio Mamore virus. Viral nucleotide sequences from two C. callosus were 87-88% similar to the sequence of Laguna Negra virus. The viral sequence from the C. callosus was 99% identical to viral sequences obtained from the HPS patient in this area, implicating C. callosus as the host and Laguna Negra virus as the agent responsible for the HPS case near Concepcion.


Subject(s)
Hantavirus Pulmonary Syndrome/epidemiology , Hantavirus Pulmonary Syndrome/transmission , Orthohantavirus/genetics , Rodentia/virology , Animals , Bolivia/epidemiology , Disease Reservoirs , Genotype , Orthohantavirus/classification , Orthohantavirus/isolation & purification , Hantavirus Pulmonary Syndrome/blood , Humans , Molecular Sequence Data , Phylogeny , RNA, Viral/analysis , Rats , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...